NIHR Maudsley BRC Blog

Our latest news & events

Novavax trial reveals 89.3% effectiveness in preventing COVID-19

Interim analysis of study shows that the NIHR-supported Novavax COVID-19 vaccine is 89.3% effective at preventing COVID-19, including effectiveness against the new variants of concern.

By NIHR Wellcome King's Clinical Research Facility at 29 Jan 2021

SIREN study finds past COVID-19 infection provides some immunity for at least five months

The first report from Public Health England's national SIREN study, supported at King's College Hospital by the King's CRF, has found that past COVD-19 infection provides 83% immunity for at least five months. However, some people may still carry the virus and transmit to other people.

By NIHR Wellcome King's Clinical Research Facility at 19 Jan 2021

New swabbing pod open at King's CRF

A new swabbing pod has been installed next to the Clinical Trials Facility at King’s College Hospital so that outpatients and trial participants who are symptomatic or have tested positive for COVID-19 can continue to receive treatment or attend follow-up appointments.

By NIHR Wellcome King's Clinical Research Facility at 8 Dec 2020

Heroin injection associated with respiratory disorder

A single case study of an individual with longstanding heroin addiction has shown heroin-induced slow and ineffective breathing, as well as apnoea, in research from the NIHR Maudsley BRC.

By NIHR Maudsley BRC at 26 Mar 2020

Study gets under way to test psilocybin for treatment-resistant depression

The NIHR-Wellcome Trust King's Clinical Research Facility has administered psilocybin to a patient with treatment-resistant depression in the first randomised controlled trial of its kind.

By NIHR Maudsley BRC at 17 Sep 2019